Genesys Ventures II LP 13D and 13G filings for Profound Medical Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 5:21 pm Sale |
2021-12-31 | 13G | Profound Medical Corp. PROF |
Genesys Ventures II LP | 455,738 2.190% |
-153,745![]() (-25.23%) |
Filing |
2021-02-16 4:35 pm Sale |
2020-12-31 | 13G | Profound Medical Corp. PROF |
Genesys Ventures II LP | 609,483 3.110% |
-300,604![]() (-33.03%) |
Filing |
2020-04-30 5:29 pm Purchase |
2019-12-31 | 13G | Profound Medical Corp. PROF |
Genesys Ventures II LP | 910,087 7.680% |
910,087![]() (New Position) |
Filing |